George Frangeskides, Exec-Chair at Alba Mineral Resources, discusses grades at the Clogau Gold Mine. Watch the full video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
plus the following maybe..(from Oct RNS)
'Commencement of MTD201 Phase 1 Study
Midatech (AIM: MTPH.L; NASDAQ: MTP), the R&D biotechnology company focused on delivering innovative oncology and rare disease products to patients, announces that further to the announcement made on 20 September 2019, its MTD201 Phase 1 study ("Study 102") for the treatment of acromegaly and neuroendocrine tumours (NET) has commenced.
This data will then be analysed, with top line results expected by the end of 2019 or early in 2020.'
Someone asked me what news I was expecting prior to end of year.....well I'd say this is news.
this is very good news .. and I'm surprised that the s/p has not quickly rallied at least well into mid to late 3'sp and stayed there.
At such low s/p levels I'm disappointed there is a meaningful seller into this afternoons buying..
(ps: I'm guessing that Armistice LLC holding RNS of this morning is internal transfers from their Master Fund to other funds of theirs instead of selling down a lot of what they took from recent raise participation?)
it's being dumped, hence the price drop
2.88p ask. now is probably a good time to buy .
IntraTrader well what did you think , just because somebody on here says 10p makes the company worth more.
Some holders who were waiting for a while to cash out just sold, the rns was quite impressive so I'd expect more people to buy when the news circulates ;)
it's deflating already, another pump and dump
not really 5p today but very good long for the next weeks.
donkelly Don't talk wet, its news that's all.
This should easily do 5p - 7p by close of play today.